General Information of the Compound
| Compound ID |
CP0576646
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[2-[4-[4-[12-[[2-(1-adamantyl)acetyl]amino]dodecyl]piperazin-1-yl]-2-methoxyanilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]phenyl]cyclopropanecarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C53H72N8O4
|
||||||||||||||||||
| Molecular Weight |
885.211
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(ccc1Nc1ncc2c(C)cc(=O)n(-c3ccc(NC(=O)C4CC4)cc3)c2n1)N1CCN(CCCCCCCCCCCCNC(=O)CC23CC4CC(CC(C4)C2)C3)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C53H72N8O4/c1-37-27-49(63)61(43-17-15-42(16-18-43)56-51(64)41-13-14-41)50-45(37)36-55-52(58-50)57-46-20-19-44(31-47(46)65-2)60-25-23-59(24-26-60)22-12-10-8-6-4-3-5-7-9-11-21-54-48(62)35-53-32-38-28-39(33-53)30-40(29-38)34-53/h15-20,27,31,36,38-41H,3-14,21-26,28-30,32-35H2,1-2H3,(H,54,62)(H,56,64)(H,55,57,58)
Show/Hide
|
||||||||||||||||||
| InChIKey |
VKVAXJYSVRIXBS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00845, RAC-alpha serine/threonine-protein kinase
Protein ID: PT01131, RAC-beta serine/threonine-protein kinase
Protein ID: PT01022, RAC-gamma serine/threonine-protein kinase